Transplantation Market

Transplantation Market Size

             2020                         2024-2032      

Report	Details
Market Size Value	USD 11.6 billion by 2024
Market Size Value	USD 27.1 billion by 2032
CAGR	9.2%
Forecast Period	2024-2032
Base Year	2023
Historic Data	2020
Segments Covered	Product Type, Application, End-user and Region
Geographics Covered	North America, Europe, Asia Pacific, and RoW

Major vendors in the global transplantation market : Medtronic, Novartis AG, AbbVie Inc., Zimmer Biomet Holdings, Inc., Stryker Corporation, CSL Limited, Roche Holding AG, Pfizer Inc., Sanofi, Merck & Co., Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, AstraZeneca, GlaxoSmithKline plc, Fresenius Medical Care AG & Co. KGaA, Integra LifeSciences Holdings Corporation, Organogenesis Holdings Inc., Terumo Corporation and Others.

Market Overview

The global surge in the need for transplant organs can be attributed to an increase in the occurrence of acute diseases, leading to a higher incidence of organ failures. Conditions like diabetes and high blood pressure commonly result in end-stage renal disease, necessitating kidney transplants or dialysis as the sole treatment options to sustain a patient's life. The escalating demand for innovative tissue transplantation products and organ transplants to address organ failure is a key factor propelling the growth of the global transplantation market. A primary driver of market expansion is the growing demand for novel tissue transplantation products and organ transplants in the management of organ failure. Causes of organ failure encompass severe trauma, blood loss, poisoning, drug abuse, leukemia, sepsis, and other acute diseases. There is a global high demand for tissue and organ transplantation, particularly for vital organs like the kidney, heart, liver, and lungs. Factors such as unhealthy eating habits, alcohol consumption, sedentary life, and substance abuse contribute to organ failure, leading to an anticipated increase in the demand for transplantation products.

Rising occurrences of organ failure

Organ failure can be triggered by various factors, including severe trauma, sepsis, blood loss, poisoning, drug abuse, leukemia, and other acute illnesses. Acute illnesses are often linked to the deterioration of organ function, with conditions such as glomerular diseases, diabetes, and hypertensive nephrosclerosis potentially leading to kidney failure. Similarly, liver failure can result from cirrhosis, and heart failure may be associated with coronary heart disease. Life factors such as obesity, alcohol and drug abuse, and smoking can contribute to these conditions, ultimately culminating in organ failure. Consequently, there is a substantial global demand for tissue and organ transplantation, particularly for vital organs like bone marrow, heart, liver, kidney, and lungs. According to the U.S. Government Information on Organ Donation and Transplantation, approximately 112,000 candidates were registered on the U.S. national transplant waiting list as of March 2020. The increasing number of elderly individuals due to improved healthcare facilities has also played a role in the heightened demand for organ transplantation. Therefore, the rise in acute illnesses and the growing geriatric population are key factors driving the global increase in organ failures and the subsequent demand for organ transplantation procedures.

Market Dynamics

Drivers:

• Increasing demand for transplants
• Advances in medical technology
• Growing public awareness

Opportunities:

• Improving organ procurement
• Increasing public education
• Developed tissue banks
• Artificial Organs and Immunosuppressive Drugs to Create New Opportunities

Increasing R&D and clinical trials

The transplantation market is witnessing a notable surge in research and development (R&D) activities and clinical trials, signifying a pivotal moment in advancing treatment modalities. The intensified focus on R&D is driving exploration into innovative approaches, including precision medicine, immunomodulation therapies, and bioengineering solutions, aimed at enhancing transplant outcomes. The increased investment in clinical trials is crucial for evaluating the safety and efficacy of these groundbreaking interventions. This heightened commitment to research not only fosters the development of more refined and targeted transplantation techniques but also accelerates the translation of scientific discoveries into practical, patient-centered solutions. As the transplantation landscape undergoes significant transformation through these R&D and clinical endeavors, the potential for discovering more effective and personalized treatments becomes increasingly promising, marking a substantial stride forward in the field.

The market for Transplantation is dominated by North America.

In 2022, the transplantation market was primarily led by North America, attributed to its advanced healthcare infrastructure and the substantial presence of major biotechnology and medical device corporations in the region. According to the Organ Procurement and Transplantation Network, 118,020 individuals in the United States needed organ transplantation in 2017. The increasing prevalence of chronic illnesses like cancer, kidney diseases, and cardiac disorders has resulted in a higher incidence of organ failure. Consequently, there is a growing demand for organ donors, prompting the establishment of numerous transplant centers in the region, thereby bolstering market growth.

On the other hand, the Asia-Pacific region encompasses rapid increase in economies such as Japan, China, and India, characterized by a sizable population facing a heightened prevalence of chronic diseases. The anticipated rise in chronic illnesses culminating in organ failure is poised to propel the growth of the transplant market in this region. These countries exhibit technological advancements and provide a range of surgical procedures, fostering a thriving medical tourism sector. The cost-effectiveness of surgical procedures in the area attracts a substantial influx of patients seeking medical treatment. Consequently, the simultaneous increase in chronic diseases leading to organ failure and the surge in medical tourism has become a significant driving force behind the notable expansion of the transplantation market in the Asia-Pacific region.

The Tissue Transplantation Segment is Anticipated to Hold the Largest Market Share During the Forecast Period

Based on application, the transplantation market is segmented into organ transplantation and tissue transplantation. In 2022, tissue transplantation emerges as the dominant segment in the market, boasting a substantial market size in 2022. This dominance is attributed to the widespread adoption of procedures involving the replacement of skin, cornea, bones, heart valves, tendons, nerves, and veins, which are commonly performed worldwide. The increasing incidence of burn and accident cases is anticipated to drive the demand for tissue products. As highlighted in the European Road Safety Observatory report, Spain alone reported 102,362 injury accidents, further contributing to the demand for tissue transplantation.

Segmentations Analysis of Transplantation Market: -

• By Product Type
  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solutions
• By Application
  • Organ Transplantation
  • Tissue Transplantation
• By End-user
  • Hospitals
  • Transplantation Centers
  • Others
• By Region
  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of Latin America
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • BENELUX
    • CIS & Russia
    • Nordics
    • Austria
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Thailand
    • Indonesia
    • Malaysia
    • Vietnam
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Nigeria
    • Egypt
    • Israel
    • Turkey
    • Rest of MEA

Recent Developments

• In March 2023, The FDA granted approval for the utilization of the SynCardia Total Artificial Heart in individuals experiencing end-stage heart failure, particularly those ineligible for heart transplantation. This fully implantable artificial heart serves as both a temporary solution, functioning as a bridge to transplantation, and a permanent replacement for a failing heart.
• In February 2023, The FDA has granted approval for the application of the Enliven Organ Care System in the ex-vivo perfusion of livers intended for transplantation. This innovative device, the Enliven system, has demonstrated its capability to enhance liver function and increase survival rates for individuals undergoing transplantation.

Answers to Following Key Questions:

• What will be the Transplantation Market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers of Transplantation Market?
• What are the main forces behind worldwide Transplantation Market? Which companies dominate Transplantation Market?
• Which companies dominate Transplantation Market? Which business possibilities, dangers, and tactics did they embrace in the market?
• What are the global Insight Engines industry's suppliers' opportunities and dangers in Transplantation Market?
• What is the Insight Engines industry's regional sales, income, and pricing analysis? In the Transplantation Market, who are the distributors, traders, and resellers?
• What are the main geographic areas for various trades that are anticipated to have astounding expansion over the Transplantation Market?
• What are the main geographical areas for various industries that are anticipated to observe astounding expansion for Transplantation Market?
• What are the dominant revenue-generating regions for Transplantation Market, as well as regional growth trends?
• By the end of the forecast period, what will the market size and growth rate be?
• What are the main Transplantation Market trends that are influencing the market's expansion?
• Which key product categories dominate Transplantation Market? What is Transplantation Market’s main applications?
• In the coming years, which Transplantation Market technology will dominate the market?

Reason to purchase this Transplantation Market Report:

• Determine prospective investment areas based on a detailed trend analysis of the global Transplantation Market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different Transplantation Market segments in the top spending countries across the world and identify the opportunities each offers.
• Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels that are driving the global Transplantation Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global Transplantation Market.
• Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top Transplantation Market providers worldwide, including information about their products, alliances, recent contract wins, and financial analysis wherever available.